New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For VSI;IFF;GNC;FDO;LO;BEAM;RAD;MJN;ENR;VFC;TUP;BUD From The Last 14 Days
Check below for free stories on VSI;IFF;GNC;FDO;LO;BEAM;RAD;MJN;ENR;VFC;TUP;BUD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
September 16, 2014
08:20 EDTMJNHershey added to US Focus List, Mead removed at Citigroup
Subscribe for More Information
September 15, 2014
17:09 EDTBUDOn The Fly: Closing Wrap
Stocks on Wall Street were mixed to begin the week, as the Dow managed to register mild gains but the Nasdaq was weighed down by slides in a number of so-called "momentum stocks" like Tesla (TSLA). Investors may remain cautious in the next two sessions ahead of the Fed's much anticipated rate decision and accompanying statement, which is due Wednesday. ECONOMIC EVENTS: In the U.S., New York Fed's Empire state survey for September rose to a five-year high of 27.54. Industrial production unexpectedly dipped 0.1% in August from a downwardly revised 0.2% July gain, missing the forecast for a rise of 0.3%. Capacity utilization dropped to 78.8% last month from 79.1% previously. In China, industrial output increased 6.9% in August versus the same period a year earlier, which was its weakest advance, excluding months that fell during New Year holidays, since December 2008. Chinese retail sales growth for August came in at 11.9%, missing the consensus estimate. COMPANY NEWS: Shares of Apple (AAPL) edged down 3c, or 0.03%, to $101.63 despite the company's announcement that a record 4M iPhone 6 and iPhone 6 Plus pre-orders were placed in the first 24 hours that ordering was available. Demand for the new phones exceeds the initial pre-order supply, the company added, stating that delivery of "many" iPhone pre-orders have been pushed out to October... Microsoft (MSFT) slid 45c, or 0.97%, to $46.24 after the company confirmed an agreement to acquire Mojang, the developer for the "Minecraft" video game franchise, for $2.5B... MAJOR MOVERS: Among the notable gainers was Avanir Pharmaceuticals (AVNR), which surged $5.75, or 85.31%, to $12.49 and was upgraded to Buy from Hold at Jefferies after the company announced results from its phase II clinical trial evaluating the safety and efficacy of its treatment of agitation in patients with Alzheimer's disease. Also higher was SABMiller (SBMRY), which jumped $4.72, or 8.5%, to $60.26 after the Wall Street Journal said that ABInBev (BUD) was looking to obtain financing for an acquisition of the U.K.-based brewer and Heineken (HEINY) confirmed that it rebuffed SABMiller's approach regarding a potential transaction. The news of potential consolidation in the space also drove other beer makers highers, with Molson Coors (TAP) rising $4.20, or 5.85%, to $76.00 and Boston Beer (SAM) gaining 71c, or 0.33%, to $218.47. Among the noteworthy losers was Tesla (TSLA), which dropped $25.34, or 9.08%, to $253.86 after Morgan Stanley analyst Adam Jones wrote that he agrees with the assertion of Tesla's CEO Elon Musk that the company's stock may have gotten ahead of itself. Also lower were shares of NPS Pharmaceuticals (NPSP), which fell $5.42, or 16.56%, to $27.28 after Oppennheimer and Jefferies stated that approval of its Natpara drug for hypoparathyroidism could be delayed after concerns were raised during an FDA panel meeting, even though the advisors were in favor of approving the drug. INDEXES: The Dow rose 43.63, or 0.26%, to 17,031.14, the Nasdaq dropped 48.70, or 1.07%, to 4,518.90, and the S&P 500 declined 1.41, or 0.07%, to 1,984.13.
12:31 EDTBUDOn The Fly: Midday Wrap
Subscribe for More Information
10:50 EDTBUDBrewers climb after Heineken turns down SABMiller
Shares of beer makers SABMiller (SBMRY) and Molson Coors (TAP) are climbing after Heineken (HEINY) confirmed that it rebuffed SABMiller's approach regarding a potential acquisition. Additionally, the Wall Street Journal reported that another company in the sector, ABInBev (BUD), was looking to obtain financing for an acquisition of U.K.-based SABMiller, but that report was refuted by CNBC's David Faber. WHAT'S NEW: Heineken announced yesterday that it has been approached by SABMiller regarding a potential acquisition, but concluded that SABMiller's proposal is non-actionable. The Heineken family has informed SABMiller of its intention to "preserve the heritage and identity of Heineken as an independent company," the beer maker stated. Meanwhile, The Wall Street Journal reported, citing an unnamed source, that ABInBev is in talks with banks about financing a takeover of SABMiller. The deal could be worth nearly $122B, the newspaper added. However, CNBC's David Faber this morning disputed the accuracy of the report, saying that ABInBev was not in talks to receive financing for a SABMiller takeover and that the companies were not in discussions about a transaction. ANALYST REACTION: In a note to investors on Saturday, ISI Group analyst Robert Ottenstein recommended buying shares of Molson Coors, SABMiller. and ABInBev. SABMiller's attempt to buy Heineken could indicate that the U.K-based company thinks that it will receive a takeover offer from ABInBev in the near-term, the analyst believes. It's likely that SABMiller expects an offer by ABInBev "in the foreseeable future," causing the British brewer to explore all strategic options, Ottenstein contended. Additionally, Ottenstein does not believe that SABMiller is looking to prevent a takeover by ABInBev and he does not expect Heineken to sell itself. Heineken's management said in 2012 that the family which controls the company takes a very long-term view of the business and is unlikely to permit it to be sold, Ottenstein stated. WHAT'S NOTABLE: In June, research firm ISI Group said that if ABInBev were to acquire SABMiller, Molson Coors would likely buy SABMiller's 58% stake in their U.S. joint venture, MillerCoors , at an attractive, very accretive price. Such a deal would provide AmInBev with a solution to U.S. anti-trust issues, the firm stated. Also in June, Molson Coors CEO Peter Swinburn said he wouldn't rule out buying SABMiller's stake in MillerCoors if it becomes available. PRICE ACTION: In mid-morning trading, Molson Coors climbed nearly 7% to $76.66, SABMiller rallied 10% to $61.24, and ABInBev gained 3% to $114.50 and Heineken rose 2% to $39.19.
10:30 EDTVFCVF Corp. to host investor meeting
Subscribe for More Information
09:04 EDTBUDAB InBev not in talks for financing for SABMiller deal, CNBC reports
AB InBev (BUD) is not in talks for financing for a deal with SABMiller (SBMRY) and the companies are not currently in talks about any transaction, according to CNBC's David Faber, citing sources. Faber's reporting refutes an earlier report from The Wall Street Journal, which also cited a source.
09:03 EDTBUDAB InBev not in talks about financing for SABMiller bid, CNBC's Faber says
Subscribe for More Information
07:40 EDTBUDAnheuser-Busch InBev volatility expected to move on consolidation report
Anheuser-Busch InBev (BUD) volatility is expected to move on sources say that SABMiller (SBMRY) has approached Heineken (HINKY) about an offer for the brewer to help defend itself against a possible takeover attempt by Anheuser-Busch, says Bloomberg. Overall option implied volatility of 18 is near its 26-week average of 19 according to Track Data, suggesting non-directional price movement.
07:32 EDTBUDAB InBev in talks with banks for financing for SABMiller deal, WSJ reports
Subscribe for More Information
September 14, 2014
15:55 EDTBUDSABMiller said to approach Heinenken with offer, Bloomberg says
Subscribe for More Information
September 12, 2014
10:35 EDTGNC, VSIVitamin Shoppe may consider selling itself, analyst says
Vitamin retailer Vitamin Shoppe (VSI) could be considering selling itself after its 52 year old CEO announced that he would retire, Sterne Agee wrote in a note to investors today. WHAT'S NEW: After Vitamin Shoppe announced on September 10 that its CEO Tony Truesdale would retire effective June 2015, Sterne Agee analyst Charles Grom wrote that the news was surprising, in light of Truesdale's age and several initiatives recently carried out by the company. Given Truesdale's departure and the lack of available high-caliber retail management talent, along with Vitamin Shoppe's recent move into manufacturing via its acquisition of nutritional product maker Nutri-Force, Vitamin Shoppe's board may be considering selling the company, the analyst believes. Vitamin Shoppe could be weighing selling itself to competitor GNC (GNC) or a private equity firm, Grom wrote. He kept a $53 price target and Buy rating on Vitamin Shoppe. WHAT'S NOTABLE: In a note to investors on August 11, Credit Suisse predicted that GNC and Vitamin Shoppe could combine. The merger would create $135M of synergies and grow the combined entity's earnings before interest taxes depreciation and amortization by nearly 20%, the analyst predicted. Additionally, the companies have a great deal of store overlap, and the new CEO of GNC is a former president of Vitamin Shoppe, increasing the chances that a merger would be successful, Credit Suisse stated. PRICE ACTION: In mid-morning trading, Vitamin Shoppe lost 1% to $43, while GNC advanced 1% to $39.50.
10:00 EDTFDOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:20 EDTGNC, VSIVitamin Shoppe may be weighing sale of company, says Sterne Agee
Subscribe for More Information
08:54 EDTMJNMead Johnson transforming to a balanced global story, says Goldman
Subscribe for More Information
07:20 EDTVFCVF Corp. could raise targets for Timberland at analyst day, says UBS
Subscribe for More Information
06:49 EDTFDOSome Dollar Tree owners see upside of Family Dollar offer failure, Reuters says
Analysts are saying that some Dollar Tree (DLTR) shareholders are seeing benefits if the company's $8.5B takeover of Family Dollar (FDO) falls through, by noting that the firm could broaden and repurchase stock with the $309B breakup fee while evading all the instability of a possible acquisition, reported Reuters. Reference Link
06:31 EDTFDOFamily Dollar initiated with a Neutral at UBS
Subscribe for More Information
06:15 EDTFDODollar General waiting on FTC feedback for Family Dollar deal, NY Post reports
Subscribe for More Information
05:57 EDTFDOStocks with implied volatility movement; SDS FDO
Subscribe for More Information
September 11, 2014
10:49 EDTVSIHigh option volume stocks
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use